Cameron Hassani1, Bino A Varghese1, Jorge Nieva2, Vinay Duddalwar1. 1. 1 Department of Radiology, Keck Hospital, University of Southern California, 1500 San Pablo St, 2nd Fl, Los Angeles, CA 90033. 2. 2 Department of Oncology, University of Southern California Norris Cancer Center, Los Angeles, CA.
Abstract
OBJECTIVE: Diagnostic imaging has traditionally relied on a limited set of qualitative imaging characteristics for the diagnosis and management of lung cancer. Radiomics-the extraction and analysis of quantitative features from imaging-can identify additional imaging characteristics that cannot be seen by the eye. These features can potentially be used to diagnose cancer, identify mutations, and predict prognosis in an accurate and noninvasive fashion. This article provides insights about trends in radiomics of lung cancer and challenges to widespread adoption. CONCLUSION: Radiomic studies are currently limited to a small number of cancer types. Its application across various centers are nonstandardized, leading to difficulties in comparing and generalizing results. The tools available to apply radiomics are specialized and limited in scope, blunting widespread use and clinical integration in the general population. Increasing the number of multicenter studies and consortiums and inclusion of radiomics in resident training will bring more attention and clarity to the growing field of radiomics.
OBJECTIVE: Diagnostic imaging has traditionally relied on a limited set of qualitative imaging characteristics for the diagnosis and management of lung cancer. Radiomics-the extraction and analysis of quantitative features from imaging-can identify additional imaging characteristics that cannot be seen by the eye. These features can potentially be used to diagnose cancer, identify mutations, and predict prognosis in an accurate and noninvasive fashion. This article provides insights about trends in radiomics of lung cancer and challenges to widespread adoption. CONCLUSION: Radiomic studies are currently limited to a small number of cancer types. Its application across various centers are nonstandardized, leading to difficulties in comparing and generalizing results. The tools available to apply radiomics are specialized and limited in scope, blunting widespread use and clinical integration in the general population. Increasing the number of multicenter studies and consortiums and inclusion of radiomics in resident training will bring more attention and clarity to the growing field of radiomics.
Authors: Francesco Bianconi; Mario Luca Fravolini; Sofia Pizzoli; Isabella Palumbo; Matteo Minestrini; Maria Rondini; Susanna Nuvoli; Angela Spanu; Barbara Palumbo Journal: Quant Imaging Med Surg Date: 2021-07
Authors: Fabien Maldonado; Cyril Varghese; Srinivasan Rajagopalan; Fenghai Duan; Aneri B Balar; Dhairya A Lakhani; Sanja L Antic; Pierre P Massion; Tucker F Johnson; Ronald A Karwoski; Richard A Robb; Brian J Bartholmai; Tobias Peikert Journal: Eur Respir J Date: 2021-04-01 Impact factor: 16.671
Authors: Jose Arimateia Batista Araujo-Filho; Maria Mayoral; Junting Zheng; Kay See Tan; Peter Gibbs; Annemarie Fernandes Shepherd; Andreas Rimner; Charles B Simone; Gregory Riely; James Huang; Michelle S Ginsberg Journal: Ann Thorac Surg Date: 2021-04-09 Impact factor: 5.102
Authors: Thomas Weikert; Tugba Akinci D'Antonoli; Jens Bremerich; Bram Stieltjes; Gregor Sommer; Alexander W Sauter Journal: Contrast Media Mol Imaging Date: 2019-07-01 Impact factor: 3.161